What Is Multiple Myeloma?

JAMA. 2022 Feb 1;327(5):497. doi: 10.1001/jama.2021.25306.

Authors

Juliet Silberstein¹, Sascha Tuchman^{2

3}, Shakira J Grant^{2

3

4}

Affiliations

¹ Department of Medicine, The University of North Carolina at Chapel Hill.
² Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill.
³ Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill.
⁴ Center for Aging and Health, Division of Geriatrics, Department of Medicine, The University of North Carolina at Chapel Hill.

PMID: 35103765
DOI: 10.1001/jama.2021.25306

No abstract available

Publication types

Patient Education Handout

MeSH terms

Biopsy
Bone Marrow / pathology
Bortezomib / therapeutic use
Dexamethasone / therapeutic use
Drug Therapy, Combination / methods
Hematopoietic Stem Cell Transplantation
Humans
Lenalidomide / therapeutic use
Multiple Myeloma* / complications
Multiple Myeloma* / diagnosis
Multiple Myeloma* / epidemiology
Multiple Myeloma* / therapy
United States / epidemiology

Substances

Bortezomib
Dexamethasone
Lenalidomide

Grants and funding